siRNA-directed inhibition of HIV-1 infection. [Nat Med. 2002] - PubMed

Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. [J Virol. 2003]
Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages.
Song E, Lee SK, Dykxhoorn DM, Novina C, Zhang D, Crawford K, Cerny J, Sharp PA, Lieberman J, Manjunath N, et al. J Virol. 2003 Jul; 77(13):7174-81.
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. [AIDS. 2002]
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Martínez MA, Gutiérrez A, Armand-Ugón M, Blanco J, Parera M, Gómez J, Clotet B, Esté JA. AIDS. 2002 Dec 6; 16(18):2385-90.
Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4. [Gene Ther. 2004]
Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N, Fang J, Mukhtar M, Acheampong E, Pomerantz RJ. Gene Ther. 2004 Dec; 11(23):1703-12.
Review Gene silencing of HIV-1 by RNA interference. [Antivir Chem Chemother. 2004]
Review Gene silencing of HIV-1 by RNA interference.
Takaku H. Antivir Chem Chemother. 2004 Mar; 15(2):57-65.
Review Control of HIV-1 replication by RNA interference. [Virus Res. 2004]
Review Control of HIV-1 replication by RNA interference.
Lee NS, Rossi JJ. Virus Res. 2004 Jun 1; 102(1):53-8.

The GB Virus C (GBV-C) NS3 Serine Protease Inhibits HIV-1 Replication in a CD4+ T Lymphocyte Cell Line without Decreasing HIV Receptor Expression. [PLoS One. 2012]
The GB Virus C (GBV-C) NS3 Serine Protease Inhibits HIV-1 Replication in a CD4+ T Lymphocyte Cell Line without Decreasing HIV Receptor Expression.
George SL, Varmaz D, Tavis JE, Chowdhury A. PLoS One. 2012; 7(1):e30653. Epub 2012 Jan 23.
HIVsirDB: a database of HIV inhibiting siRNAs. [PLoS One. 2011]
HIVsirDB: a database of HIV inhibiting siRNAs.
Tyagi A, Ahmed F, Thakur N, Sharma A, Raghava GP, Kumar M. PLoS One. 2011; 6(10):e25917. Epub 2011 Oct 11.
The effect of murine cytomegalovirus IE-3 specific shRNA is dependent on intragenic target site due to multiple transcription initiation sites. [Herpesviridae. 2011]
The effect of murine cytomegalovirus IE-3 specific shRNA is dependent on intragenic target site due to multiple transcription initiation sites.
Marshall B, Zhang M, Atherton SS. Herpesviridae. 2011 Sep 18; 2(1):9. Epub 2011 Sep 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Probe
Molecular reagents in the Probe database that cite the current articles. References in Probe are provided by submitters of the data.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

siRNA-directed inhibition of HIV-1 infection.
siRNA-directed inhibition of HIV-1 infection.
Nat Med. 2002 Jul ;8(7):681-6. Epub 2002 Jun 3 .

PubMed
Silencing viral infection.
Silencing viral infection.
PLoS Med. 2006 Jul ;3(7):e242. Epub 2006 Jul 25 .

PubMed
Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-indepen...
Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death.
Cell. 2008 May 16 ;133(4):681-92.

PubMed
Comparative study of immunomodulatory properties of muramyl peptides on immune s...
Comparative study of immunomodulatory properties of muramyl peptides on immune system cells of young and old mice.
Immunopharmacol Immunotoxicol. 1994 May ;16(2):149-63.

PubMed
A 'second life' agenda. Psychiatric research issues raised by protease inhibitor...
A 'second life' agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome.
Arch Gen Psychiatry. 1997 Nov ;54(11):1049-53.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed